Cleared Traditional

K211498 - Nonin OTC Pulse Oximeter Model 3250 (FDA 510(k) Clearance)

Class II Anesthesiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2024
Decision
1279d
Days
Class 2
Risk

K211498 is an FDA 510(k) clearance for the Nonin OTC Pulse Oximeter Model 3250. Classified as Pulse Oximeter For Over-the-counter Use (product code OLK), Class II - Special Controls.

Submitted by Nonin Medical, Inc. (Plymouth, US). The FDA issued a Cleared decision on November 13, 2024 after a review of 1279 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 870.2700 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Anesthesiology submissions.

View all Nonin Medical, Inc. devices

Submission Details

510(k) Number K211498 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 14, 2021
Decision Date November 13, 2024
Days to Decision 1279 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
1140d slower than avg
Panel avg: 139d · This submission: 1279d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code OLK Pulse Oximeter For Over-the-counter Use
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2700
Definition Non-wearable, Fingertip Pulse Oximeter Intended For Over-the-counter Use For Non-continuous Monitoring
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Consultant

Covance by Labcorp
Sheila Mena

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.